India SEBI Compliance Enforcement Orders — April 23, 2026

Q4 revenue grew 6.6% YoY (4.1% CC) to $3.7 Bn, outperforming FY growth of 3.1% and signaling resilience in key segments

Communication segment +12.6% YoY and Life Sciences +15.5% YoY, driving outsized growth vs overall 6.6%

Recommended final dividend ₹25/share (record date June 10, 2026), maintaining strong capital return policy

CEO Salil Parekh granted stock worth ₹51.75 Cr, aligning management with shareholders and boosting conviction

Attrition improved to 12.6% LTM, down from prior trends, indicating stabilizing talent retention

FY26 revenue $14.9 Bn (+3.1% YoY reported), modest but steady in competitive IT landscape [NEUTRAL/BULLISH]

Retail segment +2.9% YoY growth provides modest stability amid mixed performance

Q4 revenue declined 1.2% QoQ (-1.3% CC), extending softness from prior quarter

Hi-Tech segment declined 1.5% YoY, underperforming other segments and signaling weakness

Employee headcount fell to 328,594 (down QoQ), reflecting cost controls but potential demand concerns

Utilization dropped to 79.7%, pressuring near-term productivity vs prior levels

Mixed segment performance with 2/4 segments accelerating YoY but Hi-Tech lagging

Q4 revenue -1.2% QoQ (-1.3% CC) for second consecutive quarter, risking FY27 slowdown

Utilization declined to 79.7%, down QoQ and signaling underutilization amid $3.7 Bn revenue

Headcount down QoQ to 328,594, potential indicator of muted demand or cost-cutting

Hi-Tech -1.5% YoY decline, outlier underperformance vs Communication/Life Sciences growth

FY26 revenue only +3.1% YoY reported, below historical IT peers' averages

Proposed auditor change to BSR & Co. LLP/KPMG for FY28, watch for SEBI scrutiny on rotation

Postal ballot for directors (Jurgens 2026-2029, Potier 2026-2031), potential delays if not approved

Explicit mixed sentiment on filing, balancing growth with operational declines

Absence of explicit FY27 forward-looking targets amid QoQ weakness

Dividend payout post-QoQ decline could strain if growth doesn't rebound

₹25 final dividend with record date June 10, 2026—buy before ex-date for yield capture

₹51.75 Cr stock grants to CEO Parekh enhance long-term conviction, potential stock catalyst

Communication +12.6% YoY and Life Sciences +15.5% YoY—position for sector tailwinds

12.6% LTM attrition improvement signals talent stabilization, margin upside potential

Postal ballot approvals for directors Jurgens/Potier strengthen board, ESG appeal

BSR & KPMG appointments for FY28 could signal cleaner compliance, reducing regulatory overhang

Headcount reduction QoQ amid 79.7% utilization sets up for efficiency gains if demand rebounds

Modest 3.1% FY growth at high materiality (9/10) may undervalue strong segments

Monitor for Q1 FY27 rebound from -1.2% QoQ base, entry for growth rotation

6.6% Q4 YoY beat FY avg, opportunity in IT services dip-buying

Single filing shows 6.6% Q4 YoY / 3.1% FY YoY revenue, implying broader IT slowdown vs historical 10%+ [IMPLICATION: Favor segment leaders like Life Sciences]

50% segments (Comm/Life Sci) >10% YoY growth, Hi-Tech -1.5% decline—watch rotation to high-growth verticals [IMPLICATION: Portfolio rebalance needed]

₹25/share final dividend post-results underscores IT firms' capital returns amid tepid growth [IMPLICATION: Attractive for income strategies]

Attrition down to 12.6% LTM (positive) but headcount/utilization down QoQ—IT wage pressure easing [IMPLICATION: Margin expansion potential]

Auditor/director changes via postal ballot/AGM highlight standard SEBI governance in IT [IMPLICATION: Low enforcement risk for largecaps]

Utilization 79.7% drop with headcount cut positions IT for rebound if volumes recover [IMPLICATION: Catalyst for 2027 upside]

Dividend ₹25/share entitlement, monitor ex-date flows around June 10, 2026 [June 10, 2026]

Approvals for BSR & Co. LLP/KPMG auditors and directors Jurgens/Potier, governance catalyst [2027]

Track QoQ revenue recovery from -1.2% base, guidance debut potential [Q1 FY27]

Vesting timeline for ₹51.75 Cr stock to Salil Parekh, insider alignment signal [Ongoing FY27]

79.7% level for rebound, QoQ trend vs headcount stabilization [Next quarterly]

-1.5% YoY decline, watch for turnaround or further weakness [Q1 FY27]

12.6% LTM stability, monitor LTM vs prior peaks [Next quarterly]

Director appointments (Jurgens 2026-2029, Potier 2026-2031), approval risks [Near-term]